Literature DB >> 25182006

[Occlusion of the aorta and iliac arteries].

J Kosan1, H Riess, G Atlihan, H Diener, T Kölbel, E S Debus.   

Abstract

Occlusion of the aorta and the iliac arteries leads to an insufficient perfusion of the legs and the genital and gluteal region. The occurring symptoms may be variable, mainly depending on the collateralization network of the internal iliac artery (IIA) circulation. Various differential diagnoses need to be excluded. Invasive therapy is almost always inevitable if an aortoiliac stenosis is established. With good patency rates and low mortality rates the indications for reconstructive procedures are liberally interpreted; therefore, invasive therapy can be performed in the early stages of claudication in certain situations. Due to lower invasiveness and therefore lower risk of complications while showing comparable long-term patency rates, endovascular treatment is the preferred first line therapy for the majority of occlusions. Because aortoiliac occlusion processes also affect patients who are actively involved in a professional career, the indications for invasive therapy can be attained even in Fontaine stage IIa.

Entities:  

Mesh:

Year:  2014        PMID: 25182006     DOI: 10.1007/s00104-014-2720-3

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  34 in total

1.  Calcium score: a new risk factor for colorectal anastomotic leakage.

Authors:  Niels Komen; Pieter Klitsie; Jan Willem Dijk; Juliette Slieker; John Hermans; Klaas Havenga; Matthijs Oudkerk; Joost Weyler; Gert-Jan Kleinrensink; Johan F Lange
Journal:  Am J Surg       Date:  2010-09-27       Impact factor: 2.565

2.  Total laparoscopic aortobifemoral bypass: short- and middle-term results.

Authors:  Isabelle Di Centa; Marc Coggia; Pierre Cerceau; Isabelle Javerliat; Pascal Alfonsi; Alain Beauchet; Olivier Goëau-Brissonnière
Journal:  Ann Vasc Surg       Date:  2008-03       Impact factor: 1.466

3.  Pioneer re-entry device for iliac chronic total occlusion: truly a paradigm shift.

Authors:  Ahmed Rezq; Alessandro Aprile; Giuseppe Sangiorgi
Journal:  Catheter Cardiovasc Interv       Date:  2013-05-02       Impact factor: 2.692

4.  Long-term outcomes of endovascular therapy for aortoiliac bifurcation lesions in the real-AI registry.

Authors:  Hideaki Aihara; Yoshimitsu Soga; Osamu Iida; Kenji Suzuki; Junichi Tazaki; Yoshiaki Shintani; Yusuke Miyashita
Journal:  J Endovasc Ther       Date:  2014-02       Impact factor: 3.487

Review 5.  Review of direct anatomical open surgical management of atherosclerotic aorto-iliac occlusive disease.

Authors:  K W H Chiu; R S M Davies; P G Nightingale; A W Bradbury; D J Adam
Journal:  Eur J Vasc Endovasc Surg       Date:  2010-03-20       Impact factor: 7.069

Review 6.  Covered stents for aortoiliac reconstruction of chronic occlusive lesions.

Authors:  F A B Grimme; P A Goverde; J A Van Oostayen; C J Zeebregts; M M P J Reijnen
Journal:  J Cardiovasc Surg (Torino)       Date:  2012-06       Impact factor: 1.888

Review 7.  Geriatric syndromes--vascular disorders?

Authors:  Timo E Strandberg; Kaisu H Pitkälä; Reijo S Tilvis; Desmond O'Neill; Timo J Erkinjuntti
Journal:  Ann Med       Date:  2012-10-16       Impact factor: 4.709

8.  Long-term outcome following stent reconstruction of the aortic bifurcation and the role of geometric determinants.

Authors:  Melhem J Sharafuddin; Jamal J Hoballah; Timothy F Kresowik; William J Sharp; Jafar Golzarian; Shiliang Sun; John D Corson
Journal:  Ann Vasc Surg       Date:  2008-04-14       Impact factor: 1.466

9.  Functional assessment at the buttock level of the effect of aortobifemoral bypass surgery.

Authors:  Vincent Jaquinandi; Jean Picquet; Jean-Louis Saumet; Peyman Benharash; Georges Leftheriotis; Pierre Abraham
Journal:  Ann Surg       Date:  2008-05       Impact factor: 12.969

10.  Covered endovascular reconstruction of aortic bifurcation (CERAB) technique: a new approach in treating extensive aortoiliac occlusive disease.

Authors:  P C J M Goverde; F A B Grimme; P J E M Verbruggen; M M P J Reijnen
Journal:  J Cardiovasc Surg (Torino)       Date:  2013-06       Impact factor: 1.888

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.